Circular Genomics Finalizes Exclusive IP Licenses with Leading Global Research Institutions to Advance circRNA Blood Test for Alzheimer’s Disease

Agreements strengthen proprietary foundation, enhance partnering readiness, and support regulatory pathways for next-generation molecular diagnostics in neurology